BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37312199)

  • 1. Combination of CEACAM5, EpCAM and CK19 gene expressions in mediastinal lymph node micrometastasis is a prognostic factor for non-small cell lung cancer.
    Süer H; Erus S; Cesur EE; Yavuz Ö; Ağcaoğlu O; Bulutay P; Önder TT; Tanju S; Dilege Ş
    J Cardiothorac Surg; 2023 Jun; 18(1):189. PubMed ID: 37312199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.
    Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM
    Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.
    Dai CH; Li J; Yu LC; Li XQ; Shi SB; Wu JR
    Tumour Biol; 2013 Apr; 34(2):1245-53. PubMed ID: 23355336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between circulating lung-specific X protein messenger ribonucleic acid expression and micrometastasis and prognosis in patients with early-stage nonsmall cell lung cancer.
    Cui Y; Wang W; Yao S; Qiu Z; Cong L
    J Cancer Res Ther; 2020; 16(7):1641-1647. PubMed ID: 33565511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.
    D'Cunha J; Corfits AL; Herndon JE; Kern JA; Kohman LJ; Patterson GA; Kratzke RA; Maddaus MA
    J Thorac Cardiovasc Surg; 2002 Mar; 123(3):484-91; discussion 491. PubMed ID: 11882819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Nodal Restaging Based on CEACAM5, FGFR2b and PTPN11 Expression Adds No Relevant Clinical Information in Resected Non-Small Cell Lung Cancer.
    Macia I; Aiza G; Ramos R; Escobar I; Rivas F; Ureña A; Aso S; Rosado G; Rodriguez-Taboada P; Deniz C; Nadal E; Capella G
    J Invest Surg; 2022 Feb; 35(2):315-324. PubMed ID: 33342327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
    Wang WB; Cui YG; Yao SY
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node occult micrometastasis in patients with non-small cell lung carcinoma: genetic diagnosis and its impact on prognosis.
    Wang Z; Liu XY; Liu FY; Chen JH
    Ai Zheng; 2003 Nov; 22(11):1204-8. PubMed ID: 14613654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
    Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
    Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transducer and activator of transcription 3 overexpression promotes lymph node micrometastasis in early-stage non-small cell lung cancer.
    Yu Y; Zhao Q; He XP; Wang Z; Liu XY; Zhang ZP
    Thorac Cancer; 2018 May; 9(5):516-522. PubMed ID: 29575778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and meta-analysis of the prognostic impact of lymph node micrometastasis and isolated tumour cells in patients with stage I-IIIA non-small cell lung cancer.
    Hüyük M; Fiocco M; Postmus PE; Cohen D; von der Thüsen JH
    Histopathology; 2023 Apr; 82(5):650-663. PubMed ID: 36282087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
    Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
    Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEACAM5, KLK6, SLC35D3, POSTN, and MUC2 mRNA Analysis Improves Detection and Allows Characterization of Tumor Cells in Lymph Nodes of Patients Who Have Colon Cancer.
    Olsson LM; Lindmark GE; Israelsson ACE; Korkocic D; Hammarström SG; Hammarström MKC
    Dis Colon Rectum; 2021 Nov; 64(11):1354-1363. PubMed ID: 34192710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.
    Deng XF; Liu QX; Zhou D; Min JX; Dai JG
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):21-7. PubMed ID: 25883247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of SHP-1 promoter 2 hypermethylation detection of lymph node micrometastasis in resectable stage I non-small cell lung cancer as a prognostic marker of disease recurrence.
    Vinayanuwattikun C; Chantranuwat P; Sriuranpong V; Mutirangura A
    Int J Clin Oncol; 2014 Aug; 19(4):586-92. PubMed ID: 23824557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.